BEONE MEDICINES LTD. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/59bb1967-3b21-4bac-b655-d0f9ddc4aaba/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $447.1M | 2025-01-01 – 2025-12-31 | evidence 0001628280-26-011946 |
| FY 2024 | $-568.2M | 2024-01-01 – 2024-12-31 | evidence 0001651308-25-000031 |
| FY 2023 | $-1.2B | 2023-01-01 – 2023-12-31 | evidence 0001651308-24-000014 |
| FY 2022 | $-1.8B | 2022-01-01 – 2022-12-31 | evidence 0001651308-23-000036 |
| FY 2021 | $-1.4B | 2021-01-01 – 2021-12-31 | evidence 0001651308-22-000032 |
| FY 2020 | $-1.7B | 2020-01-01 – 2020-12-31 | evidence 0001651308-21-000039 |
| FY 2019 | $-959.9M | 2019-01-01 – 2019-12-31 | evidence 0001651308-20-000020 |
| FY 2018 | $-705.8M | 2018-01-01 – 2018-12-31 | evidence 0001651308-19-000018 |
| FY 2017 | $-98.5M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001303 |
| FY 2016 | $-117.1M | 2016-01-01 – 2016-12-31 | evidence 0001047469-17-001890 |
| FY 2015 | $-56.7M | 2015-01-01 – 2015-12-31 | evidence 0001047469-17-001890 |
| FY 2014 | $-15.8M | 2014-01-01 – 2014-12-31 | evidence 0001047469-17-001890 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).